Chris joined Genome Opinion in 2018 and leads finance, investor relations and business administrational functions. Chris started out as an investment banking analyst at Morgan Stanley, focusing on M&A and IPO transactions. Previously, Chris also worked as a member of the North Asia CSBD (Corporate Strategy & Business Development) team of The Walt Disney Company.


  • B.A. Economics, Yonsei University

Chris Han

Chief Financial Officer